Concerns related to the interactions between COVID-19 vaccination and cancer/cancer treatment were barriers to complete primary vaccination series among Chinese cancer patients: A multicentre cross-sectional survey

References

• Sikkema KJ, Abler L, Hansen NB, Wilson PA, Drabkin AS, Kochman A, MacFarlane JC, DeLorenzo A, Mayer G, Watt MH, et al. Positive choices: outcomes of a brief risk reduction intervention for newly HIV-diagnosed men who have sex with men. AIDS Behav. 2014;18(9):1808–12. doi:10.1007/s10461-014-0782-3.
   PubMed Web of Science ®Google Scholar
• Carrico AW, Nation A, Gómez W, Sundberg J, Dilworth SE, Johnson MO, Moskowitz JT, Rose CD. Pilot trial of an expressive writing intervention with HIV-Positive methamphetamine-using men who have sex with men. Psychol Addict Behav. 2014;29(2):277–82. doi:10.1037/adb0000031.
   PubMed Web of Science ®Google Scholar
• Cao W, Chen H-D, Yu Y-W, Li N, Chen W-Q. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91. doi:10.1097/CM9.0000000000001474.
   PubMed Web of Science ®Google Scholar
• Harrison SL, Fazio-Eynullayeva E, Lane DA, Underhill P, Lip GYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: a federated electronic medical record analysis. PLoS Med. 2020;17(9):e1003321. doi:10.1371/journal.pmed.1003321.
   PubMed Web of Science ®Google Scholar
• Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19. JAMA Netw Open. 2020;3(12):e2029058. doi:10.1001/jamanetworkopen.2020.29058.
   PubMed Web of Science ®Google Scholar
• Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335–7. doi:10.1016/S1470-2045(20)30096-6.
   PubMed Web of Science ®Google Scholar
• Wang QQ, Berger NA, Xu R. Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection. JAMA Oncol. 2021;7(2):220–7. doi:10.1001/jamaoncol.2020.6178.
   PubMed Web of Science ®Google Scholar
• Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, Zhang Z, You H, Wu M, Zheng Q, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020;10(6):783–91. doi:10.1158/2159-8290.CD-20-0422.
   PubMed Web of Science ®Google Scholar
• Rugge M, Zorzi M, Guzzinati S. SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer. Nat Cancer. 2020;1(8):784–8. doi:10.1038/s43018-020-0104-9.
   PubMedGoogle Scholar
• Joharatnam-Hogan NN, Daniel Hochhauser D, Shiu K-K, Rush H, Crolley V, Butcher E, Sharma A, Muhammad A, Vasdev N, Anwar M, et al. LBA83 outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience. Ann Oncol. 2020;31:S1209–S1209. doi:10.1016/j.annonc.2020.08.2324.
   Google Scholar
• Meng YF, Lu W, Guo E, Liu J, Yang B, Wu P, Lin S, Peng T, Fu Y, Li F, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13(1). doi:10.1186/s13045-020-00907-0.
   Web of Science ®Google Scholar
• Fujita K, Ito T, Saito Z, Kanai O, Nakatani K, Mio T. Impact of COVID-19 pandemic on lung cancer treatment scheduling. Thorac Cancer. 2020;11(10):2983–6. doi:10.1111/1759-7714.13615.
   PubMed Web of Science ®Google Scholar
• Cavanna L, Citterio C, Toscani I. COVID-19 vaccines in cancer patients. Seropositivity and safety. Systematic review and meta-analysis. Vaccines (Basel). 2021;9(9):1048. doi:10.3390/vaccines9091048.
   PubMed Web of Science ®Google Scholar
• American Cancer Society. COVID-19 vaccines in people with cancer. [accessed 2023 May 12]. https://www.cancer.org/cancer/managing-cancer/coronavirus-covid-19-and-cancer/covid-19-vaccines-in-people-with-cancer.html.
   Google Scholar
• World Health Organization. COVID-19 advice for the public: getting vaccinated. 2022. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/advice.
   Google Scholar
• National Comprehensive Cancer Network. Recommendations of the national comprehensive cancer network® (NCCN®) advisory committee on COVID-19 vaccination and pre-exposure prophylaxis*. 2022. https://www.nccn.org/docs/default-source/covid-19/2021_covid-19_vaccination_guidance_v5-0.pdf?sfvrsn=b483da2b_114.
   Google Scholar
• Centers for Disease Control and Prevention. Cancer survivors-staying well during COVID-19. 2022. https://www.cdc.gov/cancer/survivors/staying-well-during-covid-19.htm.
   Google Scholar
• European Centre for Disease Prevention and Control. Vaccines-efficacy, effectiveness and duration of immunity - EU/EEA authorised COVID-19 vaccines. 2022. https://www.ecdc.europa.eu/en/covid-19/latest-evidence/vaccines.
   Google Scholar
• Gauci ML, Coutzac C, Houot R, Marabelle A, Lebbé C. SARS-CoV-2 vaccines for cancer patients treated with immunotherapies: recommendations from the French society for ImmunoTherapy of Cancer (FITC). Eur J Cancer. 2021;148:121–3. doi:10.1016/j.ejca.2021.02.003.
   PubMed Web of Science ®Google Scholar
• Garassino MC, Vyas M, de Vries EGE, Kanesvaran R, Giuliani R, Peters S. The ESMO call to action on COVID-19 vaccinations and patients with cancer: vaccinate. Monitor. Educate. Ann Oncol. 2021;32(5):579–81. doi:10.1016/j.annonc.2021.01.068.
   PubMed Web of Science ®Google Scholar
• European Society of Medical Oncology. ESMO statements on vaccination against COVID-19 in people with cancer. 2022. https://www.esmo.org/covid-19-and-cancer/covid-19-vaccination.
   Google Scholar
• Heilongjiang Province People’s Government. COVID-19 vaccination (Third Edition). 2022 [accessed 2022 June 28]. https://www.hlj.gov.cn/n200/2021/0908/c988-11022120.html.
   Google Scholar
• 徐若男, 聂建云, 王涛, 李健斌, 殷咏梅, 王晓稼, 耿翠芝, 宋尔卫, 江泽飞, 王福生. 乳腺癌患者新冠疫苗接种中国专家共识. 传染病信息. 2021;34(6):481–4.
   Google Scholar
• Chan W-L, Ho YHT, Wong CKH, Choi HCW, Lam K-O, Yuen K-K, Kwong D, Hung I. Acceptance of COVID-19 vaccination in cancer patients in Hong Kong: approaches to improve the vaccination rate. Vaccines. 2021;9(7):792. doi:10.3390/vaccines9070792.
   Web of Science ®Google Scholar
• Tadele Admasu F. Knowledge and proportion of COVID-19 vaccination and associated factors among cancer patients attending public hospitals of Addis Ababa, Ethiopia, 2021: a multicenter study. Infect Drug Resist. 2021;14:4865–76. doi:10.2147/IDR.S340324.
   PubMed Web of Science ®Google Scholar
• Barrière J, Gal J, Hoch B, Cassuto O, Leysalle A, Chamorey E, Borchiellini D. Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional survey. Ann Oncol. 2021;32(5):673–4. doi:10.1016/j.annonc.2021.01.066.
   PubMed Web of Science ®Google Scholar
• Moujaess E, Zeid NB, Samaha R, Sawan J, Kourie H, Labaki C, Chebel R, Chahine G, Karak FE, Nasr F, et al. Perceptions of the COVID-19 vaccine among patients with cancer: a single-institution survey. Future Oncol. 2021;17(31):4071–9. doi:10.2217/fon-2021-0265.
   PubMed Web of Science ®Google Scholar
• Brodziak A, Sigorski D, Osmola M, Wilk M, Gawlik-Urban A, Kiszka J, Machulska-Ciuraj K, Sobczuk P. Attitudes of patients with cancer towards vaccinations—results of online survey with special focus on the vaccination against COVID-19. Vaccines. 2021;9(5):411. doi:10.3390/vaccines9050411.
   PubMed Web of Science ®Google Scholar
• Chun JY, Kim SI, Park EY, Park S-Y, Koh S-J, Cha Y, Yoo HJ, Joung JY, Yoon HM, Eom BW, et al. Cancer patients’ willingness to take COVID-19 vaccination: a nationwide multicenter survey in Korea. Cancers (Basel). 2021;13(15):3883. doi:10.3390/cancers13153883.
   PubMed Web of Science ®Google Scholar
• Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, Ng RWY, Lai CKC, Boon SS, Lau JTF, et al. Acceptance of the COVID-19 vaccine based on the health belief model: a population-based survey in Hong Kong. Vaccine. 2021;39(7):1148–56. doi:10.1016/j.vaccine.2020.12.083.
   PubMed Web of Science ®Google Scholar
• Abebe H, Shitu S, Mose A. Understanding of COVID-19 vaccine knowledge, attitude, acceptance, and determinates of COVID-19 vaccine acceptance among adult population in Ethiopia. Infect Drug Resist. 2021;14:2015–25. doi:10.2147/IDR.S312116.
   PubMed Web of Science ®Google Scholar
• Gagneux-Brunon A, Detoc M, Bruel S, Tardy B, Rozaire O, Frappe P, Botelho-Nevers E. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: a cross-sectional survey. J Hosp Infect. 2021;108:168–73. doi:10.1016/j.jhin.2020.11.020.
   PubMed Web of Science ®Google Scholar
• Bou Hamdan M, Singh S, Polavarapu M, Jordan TR, Melhem NM. COVID-19 vaccine hesitancy among university students in Lebanon. Epidemiol Infect. 2021;149:e242. doi:10.1017/S0950268821002314.
   PubMed Web of Science ®Google Scholar
• Lee LYW, Starkey T, Ionescu MC, Little M, Tilby M, Tripathy AR, Mckenzie HS, Al-Hajji Y, Barnard M, Benny L, et al. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study. Lancet Oncol. 2022;23(6):748–57. doi:10.1016/S1470-2045(22)00202-9.
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. COVID-19 vaccination guidelines (First Edition). 2021. http://www.nhc.gov.cn/xcs/yqfkdt/202103/c2febfd04fc5498f916b1be080905771.shtml.
   Google Scholar
• Zhang KC, Fang Y, Cao H, Chen H, Hu T, Chen Y, Zhou X, Wang Z. Behavioral intention to receive a COVID-19 vaccination among Chinese factory workers: cross-sectional online survey. J Med Internet Res. 2021;23(3):e24673. doi:10.2196/24673.
   PubMed Web of Science ®Google Scholar
• Zhang K, Fang Y, Chan PSF, Cao H, Chen H, Hu T, Chen Y, Zhou X, Wang Z. Behavioral intention to get a booster dose of COVID-19 vaccine among Chinese factory workers. Int J Environ Res Public Health. 2022;19(9):5245. doi:10.3390/ijerph19095245.
   PubMed Web of Science ®Google Scholar
• Singh A, Lai AHY, Wang J, Asim S, Chan PSF, Wang Z, Yeoh EK. Multilevel determinants of COVID-19 vaccine uptake among South Asian Ethnic Minorities in Hong Kong: cross-sectional web-based survey. JMIR Public Health Surveill. 2021;7(11):e31707. doi:10.2196/31707.
   PubMedGoogle Scholar
• Huang X, Yan Y, Su B, Xiao D, Yu M, Jin X, Duan J, Zhang X, Zheng S, Fang Y, et al. Comparing immune responses to inactivated vaccines against SARS-CoV-2 between people living with HIV and HIV-Negative individuals: a cross-sectional study in China. Viruses. 2022:14(2). doi:10.3390/v14020277
   Web of Science ®Google Scholar
• Xu J, Chen S, Wang Y, Duan L, Li J, Shan Y, Lan X, Song M, Yang J, Wang Z. Prevalence and determinants of COVID-19 vaccination uptake were different between Chinese diabetic inpatients with and without chronic complications: a cross-sectional survey. Vaccines (Basel). 2022;10(7):994. doi:10.3390/vaccines10070994.
   PubMed Web of Science ®Google Scholar
• Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q. 1984;11(1):1–47. doi:10.1177/109019818401100101.
   PubMedGoogle Scholar
• Wang Z, Fang Y, Yu F-Y, Chan PSF, Chen S. Governmental incentives, satisfaction with health promotional materials, and COVID-19 vaccination uptake among community-dwelling older adults in Hong Kong: a random telephone survey. Vaccines (Basel). 2022;10(5):732. doi:10.3390/vaccines10050732.
   PubMed Web of Science ®Google Scholar
• Pan Y, Xin M, Zhang C, Dong W, Fang Y, Wu W, Li M, Pang J, Zheng Z, Wang Z, et al. Associations of mental health and personal preventive measure compliance with exposure to COVID-19 information during work resumption following the COVID-19 outbreak in china: cross-sectional survey study. J Med Internet Res. 2020;22(10):e22596. doi:10.2196/22596.
   PubMed Web of Science ®Google Scholar
• The State Council of the People’s Republic of China.88.01% of people in China completed COVID-19 vaccination. 2022 [cited 2022 Aug 5]. http://www.gov.cn/xinwen/2022-03/26/content_5681691.htm.
   Google Scholar
• The Government of the Hong Kong Special Administrative Region. Archive of statistics on 5th wave of COVID-19. statistics based on data up to 15 March 2022 00: 00. [accessed 2022 Mar 17]. https://www.coronavirus.gov.hk/pdf/5th_wave_statistics/5th_wave_statistics_20220315.pdf.
   Google Scholar
• Kang SJ, Jung SI. Age-related morbidity and mortality among patients with COVID-19. Infect Chemother. 2020;52(2):154–64. doi:10.3947/ic.2020.52.2.154.
   PubMed Web of Science ®Google Scholar
• Thomas SJ, Perez JL, Lockhart SP, Hariharan S, Kitchin N, Bailey R, Liau K, Lagkadinou E, Türeci Ö, Şahin U, et al. Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial. Vaccine. 2022;40(10):1483–92. doi:10.1016/j.vaccine.2021.12.046.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang L, Chen S, Lan X, Song M, Su R, Yang J, Wang Z, Xu J. Hesitancy to receive the booster doses of COVID-19 vaccine among cancer patients in China: a multicenter cross-sectional survey — four PLADs, China, 2022. China CDC Wkly. 2023;5(10):223–8. doi:10.46234/ccdcw2023.041.
   PubMedGoogle Scholar
• Mai AS, Lee ARYB, Tay RYK, Shapiro L, Thakkar A, Halmos B, Grinshpun A, Herishanu Y, Benjamini O, Tadmor T, et al. Booster doses of COVID-19 vaccines for patients with haematological and solid cancer: a systematic review and individual patient data meta-analysis. Eur J Cancer. 2022;172:65–75. doi:10.1016/j.ejca.2022.05.029.
   PubMed Web of Science ®Google Scholar
• Re D, Seitz-Polski B, Brglez V, Carles M, Graça D, Benzaken S, Liguori S, Zahreddine K, Delforge M, Bailly-Maitre B, et al. Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies. Nat Commun. 2022;13(1):864. doi:10.1038/s41467-022-28578-0.
   PubMed Web of Science ®Google Scholar
• The Government of the Hong Kong SAR. COVID-19 vaccination programme. 2021 [accessed 2021 Mar 1]. https://www.covidvaccine.gov.hk/en/programme.
   Google Scholar
• Khan QJ, Bivona CR, Martin GA, Zhang J, Liu B, He J, Li KH, Nelson M, Williamson S, Doolittle GC, et al. Evaluation of the durability of the immune humoral response to COVID-19 vaccines in patients with cancer undergoing treatment or who received a stem cell transplant. JAMA Oncol. 2022;8(7):1053–8. doi:10.1001/jamaoncol.2022.0752.
   PubMed Web of Science ®Google Scholar
• Wu J, Xia Q, Miao Y, Yu C, Tarimo, CS, Yang Y. Self-perception and COVID-19 vaccination self-efficacy among Chinese adults: a moderated mediation model of mental health and trust. J Affect Disord. 2023;333:313–20. doi:10.1016/j.jad.2023.04.047.
   PubMed Web of Science ®Google Scholar